<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to SNRIs for chronic pain - duloxetine, venlafaxine, and milnacipran for pain conditions including fibromyalgia and neuropathy.">
    <meta name="keywords" content="SNRI, duloxetine, Cymbalta, venlafaxine, chronic pain antidepressants">
    <title>SNRIs for Pain | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>SNRIs for Pain</h1><p>Antidepressants with pain-relieving properties</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Are SNRIs?</h2>
                <p>Serotonin-norepinephrine reuptake inhibitors (SNRIs) are antidepressants that also have pain-relieving properties. They work by increasing levels of serotonin and norepinephrine, which are involved in pain modulation.<sup>1</sup></p>

                <h2>How They Help Pain</h2>
                <ul>
                    <li>Enhance descending pain inhibition pathways</li>
                    <li>Norepinephrine particularly important for pain</li>
                    <li>May help even without depression</li>
                    <li>Can improve sleep and mood</li>
                </ul>

                <h2>SNRIs Used for Pain<sup>2</sup></h2>
                <h3>Duloxetine (Cymbalta)</h3>
                <ul>
                    <li>FDA approved for fibromyalgia</li>
                    <li>FDA approved for diabetic neuropathy</li>
                    <li>FDA approved for chronic musculoskeletal pain</li>
                    <li>Typical dose: 30-60 mg/day</li>
                </ul>

                <h3>Milnacipran (Savella)</h3>
                <ul>
                    <li>FDA approved for fibromyalgia</li>
                    <li>More norepinephrine activity</li>
                    <li>Twice daily dosing</li>
                </ul>

                <h3>Venlafaxine (Effexor)</h3>
                <ul>
                    <li>Used off-label for pain</li>
                    <li>Neuropathic pain, migraine prevention</li>
                    <li>Higher doses more effective for pain</li>
                </ul>

                <h2>Conditions Treated</h2>
                <ul>
                    <li>Fibromyalgia</li>
                    <li>Diabetic peripheral neuropathy</li>
                    <li>Chronic low back pain</li>
                    <li>Osteoarthritis</li>
                    <li>Migraine prevention</li>
                </ul>

                <h2>Side Effects<sup>3</sup></h2>
                <ul>
                    <li>Nausea (often improves)</li>
                    <li>Dry mouth</li>
                    <li>Constipation</li>
                    <li>Dizziness</li>
                    <li>Sweating</li>
                    <li>Sexual dysfunction</li>
                    <li>Blood pressure increase (monitor)</li>
                </ul>

                <h2>Important Notes</h2>
                <ul>
                    <li>Takes 2-4 weeks for pain benefit</li>
                    <li>Don't stop abruptly - taper</li>
                    <li>Monitor blood pressure</li>
                    <li>Drug interactions (serotonin syndrome risk)</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. <em>J Clin Pharmacol</em>. 2012;52(1):6-17.</li>
                    <li>Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia. <em>Cochrane Database Syst Rev</em>. 2008;4:CD007115.</li>
                    <li>Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. <em>Cochrane Database Syst Rev</em>. 2014;1:CD007115.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
